In spite of the evidence that SUA, ALT and WC all contribute to the onset of NAFLD, using the combination of these three indicators to assess NAFLD risk has rarely been discussed. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.